In the current study, TSPAN4 was lowly expressed in lung cancer but highly expressed in hepatocellular carcinoma, gastric cancer and glioblastoma multiforme, and high expression of TSPAN4 was associated with lower survival rates in gastric cancer and glioblastoma multiforme [20,44,45]. Here, TSPAN4 is linked to gastric cancer.